Further clinical studies with an aldose reductase inhibitor in diabetic neuropathy.
van Gerven
J M
JM
Department of Neurology, University Hospital Dijkzigt, Rotterdam, The Netherlands.
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D003922:Diabetes Mellitus, Type 1 / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology; D003929:Diabetic Neuropathies / Q000188:drug therapy* / Q000503:physiopathology; D004311:Double-Blind Method; D005073:Evoked Potentials, Somatosensory / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009281:Naphthalenes / Q000627:therapeutic use*; D009431:Neural Conduction / Q000187:drug effects
D009281:Naphthalenes; C040550:tolrestat; D000449:Aldehyde Reductase